Collectively, this study is the first to report on the discovery of the oncogenic role of IGF2BP2 in promoting lymphatic metastasis of HNSCC, indicating the broadly clinical significance of IGF2BP2 in cancer metastasis. This evidence concerns the gene IGF2BP2 and head and neck squamous cell carcinoma.